These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 26135306

  • 1. Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.
    Taguchi S, Nakagawa T, Uemura Y, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Fujimura T, Fukuhara H, Kume H, Homma Y.
    World J Urol; 2016 Feb; 34(2):163-71. PubMed ID: 26135306
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
    Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Uemura Y, Fujimura T, Fukuhara H, Kume H, Homma Y.
    Int J Urol; 2015 Jul; 22(7):638-43. PubMed ID: 25903328
    [Abstract] [Full Text] [Related]

  • 3. Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy.
    Hsieh MC, Su YL, Chiang PH, Rau KM, Chen YY, Huang CH.
    Int J Urol; 2016 May; 23(5):385-9. PubMed ID: 26992082
    [Abstract] [Full Text] [Related]

  • 4. Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy.
    Galsky MD, Moshier E, Krege S, Lin CC, Hahn N, Ecke T, Sonpavde G, Pond G, Godbold J, Oh WK, Bamias A.
    Urol Oncol; 2014 Jan; 32(1):48.e1-8. PubMed ID: 24055428
    [Abstract] [Full Text] [Related]

  • 5. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
    Necchi A, Sonpavde G, Lo Vullo S, Giardiello D, Bamias A, Crabb SJ, Harshman LC, Bellmunt J, De Giorgi U, Sternberg CN, Cerbone L, Ladoire S, Wong YN, Yu EY, Chowdhury S, Niegisch G, Srinivas S, Vaishampayan UN, Pal SK, Agarwal N, Alva A, Baniel J, Golshayan AR, Morales-Barrera R, Bowles DW, Milowsky MI, Theodore C, Berthold DR, Daugaard G, Sridhar SS, Powles T, Rosenberg JE, Galsky MD, Mariani L, RISC Investigators.
    Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
    [Abstract] [Full Text] [Related]

  • 6. Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan.
    Abe T, Ishizaki J, Kikuchi H, Minami K, Matsumoto R, Harabayashi T, Sazawa A, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.
    Urol Oncol; 2017 Feb; 35(2):38.e1-38.e8. PubMed ID: 27693091
    [Abstract] [Full Text] [Related]

  • 7. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma.
    Kobayashi M, Tanaka H, Tateishi U, Numao N, Yonese J, Ito M, Koga F, Fukushima H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.
    Int J Urol; 2019 Aug; 26(8):820-826. PubMed ID: 31140215
    [Abstract] [Full Text] [Related]

  • 8. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
    Galsky MD, Moshier E, Krege S, Lin CC, Hahn N, Ecke T, Sonpavde G, Godbold J, Oh WK, Bamias A.
    Cancer; 2013 Aug 15; 119(16):3012-9. PubMed ID: 23720216
    [Abstract] [Full Text] [Related]

  • 9. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
    Salah S, Lee JL, Rozzi A, Kitamura H, Matsumoto K, Srinivas S, Morales-Barrera R, Carles J, Al-Wardat R, Al-Rabi K, Maakoseh M.
    Clin Genitourin Cancer; 2016 Jun 15; 14(3):255-60. PubMed ID: 26552764
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
    Takemura K, Fukushima H, Ito M, Kataoka M, Nakanishi Y, Sakamoto K, Suzuki H, Tobisu KI, Koga F.
    Urol Oncol; 2019 Feb 15; 37(2):108-115. PubMed ID: 30478012
    [Abstract] [Full Text] [Related]

  • 11. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
    Mathieu R, Klatte T, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Rink M, Kluth LA, Scherr DS, Robinson BD, Shariat SF.
    Urol Oncol; 2015 Nov 15; 33(11):495.e15-22. PubMed ID: 26228160
    [Abstract] [Full Text] [Related]

  • 12. A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
    Pond GR, Agarwal N, Bellmunt J, Choueiri TK, Qu A, Fougeray R, Vaughn D, James ND, Salhi Y, Albers P, Niegisch G, Galsky MD, Wong YN, Ko YJ, Stadler WM, O'Donnell PH, Sridhar SS, Vogelzang NJ, Necchi A, Di Lorenzo G, Sternberg CN, Mehta A, Sonpavde G.
    BJU Int; 2014 May 15; 113(5b):E137-43. PubMed ID: 24219029
    [Abstract] [Full Text] [Related]

  • 13. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K, Inamoto T, Yamamoto Y, Tanigawa G, Nakayama M, Mori N, Tsujihata M, Azuma H, Nonomura N, Uemura M.
    Int J Urol; 2015 Nov 15; 22(11):1006-12. PubMed ID: 26153093
    [Abstract] [Full Text] [Related]

  • 14. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Inokuchi J, Naito S, Fujimoto H, Hara T, Sakura M, Nishiyama H, Miyazaki J, Kikuchi E, Hinotsu S, Koie T, Ohyama C, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2016 Mar 15; 23(3):224-30. PubMed ID: 26659912
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
    Lin CC, Hsu CH, Huang CY, Tsai YC, Huang KH, Cheng AL, Pu YS.
    Urology; 2007 Mar 15; 69(3):479-84. PubMed ID: 17382149
    [Abstract] [Full Text] [Related]

  • 16. Outcome of metastasectomy for urothelial carcinoma: a multi-institutional retrospective study in Japan.
    Abe T, Kitamura H, Obara W, Matsumura N, Tsukamoto T, Fujioka T, Hara I, Murai S, Shinohara N, Nonomura K.
    J Urol; 2014 Apr 15; 191(4):932-6. PubMed ID: 24211599
    [Abstract] [Full Text] [Related]

  • 17. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
    Park J, Habuchi T, Arai Y, Ohyama C, Inoue T, Hatakeyama S, Jeon SS, Kwon GY, Kwak C, Moon KC, Kim CS, Ahn H.
    J Urol; 2014 Oct 15; 192(4):1064-71. PubMed ID: 24735938
    [Abstract] [Full Text] [Related]

  • 18. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study.
    Berod AA, Colin P, Yates DR, Ouzzane A, Audouin M, Adam E, Arroua F, Marchand C, Bigot P, Soulié M, Roumiguié M, Polguer T, Gardic S, Grès P, Ravier E, Neuzillet Y, Delage F, Bodin T, Pignot G, Rouprêt M, French National Database of UUT UC.
    BJU Int; 2012 Dec 15; 110(11 Pt C):E1035-40. PubMed ID: 22568669
    [Abstract] [Full Text] [Related]

  • 19. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
    Kikuchi E, Horiguchi Y, Nakashima J, Hatakeyama N, Matsumoto M, Nishiyama T, Murai M.
    J Urol; 2005 Dec 15; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
    [Abstract] [Full Text] [Related]

  • 20. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar 15; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.